Are we ready to start studies of Th17 cell manipulation as a therapy for cancer?MIDDLETON, Gary W; ANNELS, Nicola E; PANDHA, Hardev S et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 1, pp 1-7, issn 0340-7004, 7 p.Article

CD4+ T-cell response against human papillomavirus type 16 E6 protein is associated with a favorable clinical trendKIM, Kevin H; GREENFIELD, William W; CANNON, Martin J et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 1, pp 63-70, issn 0340-7004, 8 p.Article

CXCR1 as a novel target for directing reactive T cells toward melanoma: implications for adoptive cell transfer immunotherapySAPOZNIK, Sivan; ORTENBERG, Rona; MARKEL, Gal et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 10, pp 1833-1847, issn 0340-7004, 15 p.Article

Collective action of hematopoietic cell subsets mediates anti-IL10R1 and CpG tumor immunityCHOU, Meng-Yun; AUSTIN, Cary D; KIM, Jeong M et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 7, pp 1055-1064, issn 0340-7004, 10 p.Article

Enhanced cytotoxicity and decreased CD8 dependence of human cancer-specific cytotoxic T lymphocytes after vaccination with low peptide doseLÖVGREN, Tanja; BAUMGAERTNER, Petra; WIECKOWSKI, Sébastien et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 6, pp 817-826, issn 0340-7004, 10 p.Article

Epitope-targeted cytotoxic T cells mediate lineage-specific antitumor efficacy induced by the cancer mucosa antigen GUCY2CSNOOK, Adam E; MAGEE, Michael S; MARSZALOWICZ, Glen P et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 5, pp 713-723, issn 0340-7004, 11 p.Article

Exploiting antitumor immunity to overcome relapse and improve remission durationCHEN, Lei L; XINJIAN CHEN; JIMENEZ, Arnie et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 7, pp 1113-1124, issn 0340-7004, 12 p.Article

Exposure of CD34⁺ precursors to cytostatic anthraquinone-derivatives induces rapid dendritic cell differentiation: implications for cancer immunotherapyDE VEN, Rieneke Van; REURS, Anneke W; WIJNANDS, Pepijn G. J. T. B et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 2, pp 181-191, issn 0340-7004, 11 p.Article

Extended survival observed in adoptive activated T lymphocyte immunotherapy for advanced lung cancer: results of a multicenter historical cohort studyIWAI, Kazuro; SOEJIMA, Kenzo; KAMIGAKI, Takashi et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 10, pp 1781-1790, issn 0340-7004, 10 p.Article

HP-NAP inhibits the growth of bladder cancer in mice by activating a cytotoxic Thl responseCODOLO, Gaia; FASSAN, Matteo; MUNARI, Fabio et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 1, pp 31-40, issn 0340-7004, 10 p.Article

IL-15 augments antitumoral activity of an ErbB2/HER2 cancer vaccine targeted to professional antigen-presenting cellsBURKHARDT, Ute E; SLOOTS, Arjen; JAKOBI, Vera et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 9, pp 1473-1484, issn 0340-7004, 12 p.Article

IRX-2, a novel immunotherapeutic, enhances and protects NK-cell functions in cancer patientsSCHILLING, B; HALSTEAD, E. S; SCHULER, P et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 9, pp 1395-1405, issn 0340-7004, 11 p.Article

In vivo electroporation restores the low effectiveness of DNA vaccination against HER-2/neu in agingPROVINCIALI, Mauro; BARUCCA, Alessandra; PIERPAOLI, Elisa et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 3, pp 363-371, issn 0340-7004, 9 p.Article

In vivo imaging of immunotoxin treatment using Katushka-transfected A-431 cells in a murine xenograft tumour modelPARDO, Alessa; STÖCKER, Michael; KAMPMEIER, Florian et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 10, pp 1617-1626, issn 0340-7004, 10 p.Article

Innate immune sensing of cancer: clues from an identified role for type I IFNsGAJEWSKI, Thomas F; FUERTES, Mercedes B; WOO, Seng-Ryong et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 8, pp 1343-1347, issn 0340-7004, 5 p.Article

Interleukin-1β enhances the production of soluble MICA in human hepatocellular carcinomaKOHGA, Keisuke; TATSUMI, Tomohide; HOSUI, Atsushi et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 9, pp 1425-1432, issn 0340-7004, 8 p.Article

Long-term proliferation of functional human NK cells, with conversion of CD56^dim NK cells to a CD56^bright phenotype, induced by carcinoma cells co-expressing 4-1BBL and IL-12DOWELL, Alexander C; OLDHAM, Kimberley A; BHATT, Rupesh I et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 5, pp 615-628, issn 0340-7004, 14 p.Article

Macrophage polarization induced by neuropeptide methionine enkephalin (MENK) promotes tumoricidal responsesWENNA CHEN; JINLING LIU; JINGJUAN MENG et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 10, pp 1755-1768, issn 0340-7004, 14 p.Article

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcomeYINGZI GE; DOMSCHKE, Christoph; BECKHOVE, Philipp et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 3, pp 353-362, issn 0340-7004, 10 p.Article

Muscle CARs and TcRs: turbo-charged technologies for the (T cell) massesKALOS, Michael.Cancer immunology and immunotherapy. 2012, Vol 61, Num 1, pp 127-135, issn 0340-7004, 9 p.Article

Phase I trial of tremelimumab in combination with short-term androgen deprivation in patients with PSA-recurrent prostate cancerMCNEEL, Douglas G; SMITH, Heath A; EICKHOFF, Jens C et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 7, pp 1137-1147, issn 0340-7004, 11 p.Article

Re-purposing cancer therapeutics for breast cancer immunotherapyEMENS, Leisha A.Cancer immunology and immunotherapy. 2012, Vol 61, Num 8, pp 1299-1305, issn 0340-7004, 7 p.Article

Recombinant human CD137L for cancer immunotherapy: effects of different fusions and linkers on its activitySHUZHEN WANG; JUNFANG LV; PENG WANG et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 4, pp 489-495, issn 0340-7004, 7 p.Article

Regulation of autologous immunity to the mouse 5T4 oncofoetal antigen: implications for immunotherapyCASTRO, Fernanda V; AL-MUFTAH, Mariam; MULRYAN, Kate et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 7, pp 1005-1018, issn 0340-7004, 14 p.Article

Rituximab-induced direct inhibition of T-cell activationSTROOPINSKY, Dina; KATZ, Tamar; ROWE, Jacob M et al.Cancer immunology and immunotherapy. 2012, Vol 61, Num 8, pp 1233-1241, issn 0340-7004, 9 p.Article